Wellington Management Group LLP Sarepta Therapeutics, Inc. Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 2,530,455 shares of SRPT stock, worth $46.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,530,455
Previous 2,646,619
4.39%
Holding current value
$46.2 Million
Previous $169 Million
74.38%
% of portfolio
0.01%
Previous 0.03%
Shares
23 transactions
Others Institutions Holding SRPT
# of Institutions
462Shares Held
83.3MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$85.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$81.8 Million0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY2.24MShares$41 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...